Nipride Rtu
Product Images NDC 51754-1018

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Nipride Rtu (NDC 51754-1018). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Exela Pharma Sciences, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 01

Image 01
This is a description of a medication called Sodium Nitroprusside for intravenous infusion. The solution comes in a 80 mL container, with each mL containing 10mg of sodium nitroprusside and 450mg of sodium chloride. The medication comes in a ready-to-use solution and should be protected from light until use. It is important to discard any unused solution. This medication is only available by prescription and prescribing information is included.*
FDA Label Image

Image 02

FDA Label Image

Image 03

Image 03
NIPRIDE'RTU is a medication available for intravenous infusion. It contains sodium nitroprusside at a concentration of 0.5 mg/mL in 0.9% sodium chloride injection. The medication is available in a single-use 100 mL vial, and any unused portion should be discarded. The medication should be protected from light and stored in the provided carton until use. It should be stored at temperatures between 20°C to 25°C (68°F to 77°F). Usual dosing information is available through prescribing information. This medication is for prescription use only.*
FDA Label Image

Image 04

Image 04
NIPRIDE is a prescription drug contained in a single dose vial of 100ml. It consists of 20mg of Sodium Nitroprusside and 0.9% Sodium Chloride. The drug is meant for intravenous infusion only and should be protected from light, stored in its carton until use. Rx Only NDC 51754-1029-1 is provided with manufacturing and expiry details on the packaging. The recommended dose of NIPRIDE should be taken as per the doctor's guidance. It is manufactured by Exela Pharma Sc in Lenair, NC 28645 USA.*
FDA Label Image

Image 05

Image 05
This appears to be a mix of images, drawings, and text which couldn't be recognized due to issues with the . Therefore, it is not possible to generate a useful description.*
FDA Label Image

Image 06

FDA Label Image

Image Description (Spl Image1 Structure)

Image Description (Spl Image1 Structure)
This is a chemical formula or equation for Sodium Nitroprusside along with its molecular weight and water concentration. It is not sufficient to provide a useful description.*
FDA Label Image

Image Description (Spl Image2 Metabolism Flow)

Image Description (Spl Image2 Metabolism Flow)
This text appears to be a table or chart on the metabolism of sodium nitroprusside, including the presence of active thiosulfate and cytochromes, as well as cyanide. However, it is difficult to determine the exact information or context without further information or analysis.*
FDA Label Image

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.